Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4370716 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4368679 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4375048 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4369043 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4365196 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4366864 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4369023 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4370817 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4375099 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL4374239 | 1.00 | HPGD (0.56) | HPGDHDAC1HDAC3HDAC4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765984-B2 | Methods and systems for making thiol compounds from terminal olefinic compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-07-01 | — | — | US | disclosed |
| US-20120232297-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-09-13 | — | — | US | disclosed |
| WO-2009132010-A1 | METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232297-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | HPGD 124/4885HDAC1 3145/4885HDAC3 2472/4885 |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | HPGD 124/4885HDAC1 3145/4885HDAC3 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.